Israel-Based Gamida Cell Files for $69 Million IPO

Israel-Based Gamida Cell Files for $69 Million IPO

Source: 
BioSpace
snippet: 

Gamida Cell Ltd. filed for a $69 million initial public offering for the Nasdaq exchange, according to a filing submitted last week to the U.S. Securities and Exchange Commission, Israel’s Calcalist first reported last week.